 Partnership
September 4, 2024
BEDFORD, MA and ZÃœRICH, SWITZERLAND - September 04, 2024 - In a strategic move poised to shift the landscape of automated intralogistics, Berkshire Grey Inc. a preeminent leader in AI-enabled robotic solutions, and Kardex AS Solutions, a distinguished global provider of intralogistics and automated storage solutio...
|
Business Update
September 4, 2024
In a significant step forward in the treatment of diabetic macular edema (DME), Merck (NYSE: MRK), known as MSD outside the United States and Canada, and its wholly-owned subsidiary EyeBio have announced the initiation of the Phase 2b/3 BRUNELLO clinical trial for Restoret (MK-3000, formerly EYE103). This investigat...
|
Business Update
September 4, 2024
By In a noteworthy move set to propel the burgeoning field of gene therapy forward, Liberate Bio has announced its integration of Quantum-Si s next-generation protein sequencing platform into its research and development processes. This partnership is poised to bring about advancements in the precision and efficien...
|
|
 Product Service News
September 4, 2024
ARS Pharmaceuticals Innovates Allergy Management with Needle-Free Epinephrine Nasal Spray SummaryARS Pharmaceuticals, a biopharmaceutical firm committed to advancing allergen protection for at-risk populations, has taken significant strides towards revolutionizing allergy treatment with its product, neffy, the fir...
 Product Service News
September 4, 2024
In an ambitious move that marks a significant shift in the landscape of sports media and fan engagement, Vivid Seats has announced an exclusive multiyear media partnership with I Am Athlete, the groundbreaking platform co-founded by former NFL star Brandon Marshall. Central to this collaboration is the launch of I A...
|
|
Our most Popular Articles
|
Product Service News
November 7, 2024
Luxury Living Expands: Toll Brothers Unveils New Communities Across America In a significant move within the luxury real estate market, Toll Brothers, Inc. (NYSE:TOL), the nation s leading builder of luxury homes, has announced the opening of two new premier communities: Stella at University Park in Palm Desert, Cal...
|
Financing Agreement
July 1, 2024
In a strategic move aimed at expanding its capabilities and customer base, Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER, BAERW), one of the nation s leading aerial firefighting companies, has successfully acquired FMS Aerospace. The Huntsville, Alabama-based FMS Aerospace specializes in airframe mo...
|
Business Update
August 20, 2024
State Street Partners with Taurus to Enhance Digital Asset Solutions as Corporate Customers Show Mixed PerformanceIn a strategic move to strengthen its digital assets capabilities, State Street Corporation (NYSE: STT) has announced a groundbreaking agreement with Taurus SA, a global leader in digital asset infrastr...
|
|
|
Company News
|
Business Update
September 4, 2024
In a significant step forward in the treatment of diabetic macular edema (DME), Merck (NYSE: MRK), known as MSD outside the United States and Canada, and its wholly-owned subsidiary EyeBio have announced the initiation of the Phase 2b/3 BRUNELLO clinical trial for Restoret (MK-3000, formerly EYE103). This investigat...
|
Business Update
September 4, 2024
By In a noteworthy move set to propel the burgeoning field of gene therapy forward, Liberate Bio has announced its integration of Quantum-Si s next-generation protein sequencing platform into its research and development processes. This partnership is poised to bring about advancements in the precision and efficien...
|
Clinical Study
September 4, 2024
The release of positive topline data by Biogen Inc. (Nasdaq: BIIB) from the Phase 2/3 DEVOTE study represents a crucial advancement in the treatment landscape for spinal muscular atrophy (SMA). Announced on September 4, 2024, these findings highlight the efficacy and safety of a higher dose regimen of nusinersen in ...
|
|
|
Company News
 Management Changes
September 4, 2024
|
Company News
 Licensing Agreement
September 4, 2024
|
Company News
 Clinical Study
September 4, 2024
|
More Company News
|
Clinical Study
September 4, 2024
|
Announcement
September 4, 2024
|
Announcement
September 4, 2024
|
Clinical Study
September 4, 2024
|
Clinical Study
September 4, 2024
|
Clinical Study
September 4, 2024
|
Financing Agreement
September 4, 2024
|
Contract
September 4, 2024
|
Contract
September 4, 2024
|
Business Update
September 4, 2024
|
|
|
|
Related News
|
Business Update
|
Partnership
|
|
Stocks
|
Business Update
|
Business Update
|
Business Update
|
|
|
|
Business News
|
|
Product Service News
ARS Pharmaceuticals Innovates Allergy Management with Needle-Free Epinephrine Nasal Spray SummaryARS Pharmaceuticals, a biopharmaceutical firm committed to advancing allergen protection for at-risk populations, has taken significant strides towards revolutionizing allergy treatment with its product, neffy, the fir...
|
|
Product Service News
In an ambitious move that marks a significant shift in the landscape of sports media and fan engagement, Vivid Seats has announced an exclusive multiyear media partnership with I Am Athlete, the groundbreaking platform co-founded by former NFL star Brandon Marshall. Central to this collaboration is the launch of I A...
|
 Clinical Study
Windtree Therapeutics Inc. recently achieved a significant milestone by completing enrollment in its Phase 2b study of Istaroxime, a potential treatment for early cardiogenic shock. While the anticipation for topline data, expected in late September 2024, generates excitement in the cardiovascular medical community,...
|
|
Clinical Study
In a promising development for multiple myeloma treatment, ALX Oncology has announced the dosing of the first patients in its UMBRELLA study, a randomized Phase 1/2 clinical trial evaluating the efficacy of Evorpacept, an investigational CD47-blocking therapeutic, in combination with Sarclisa, Sanofi s approved CD38...
|
 Partnership
BEDFORD, MA and ZÃœRICH, SWITZERLAND - September 04, 2024 - In a strategic move poised to shift the landscape of automated intralogistics, Berkshire Grey Inc. a preeminent leader in AI-enabled robotic solutions, and Kardex AS Solutions, a distinguished global provider of intralogistics and automated storage solutio...
|
Our Most Popular Articles
|
 Product Service News
Luxury Living Expands: Toll Brothers Unveils New Communities Across America In a significant move within the luxury real estate market, Toll Brothers, Inc. (NYSE:TOL), the nation s leading builder of luxury homes, has announced the opening of two new premier communities: Stella at University Park in Palm Desert, Cal...
|
 Financing Agreement
In a strategic move aimed at expanding its capabilities and customer base, Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER, BAERW), one of the nation s leading aerial firefighting companies, has successfully acquired FMS Aerospace. The Huntsville, Alabama-based FMS Aerospace specializes in airframe mo...
|
 Business Update
State Street Partners with Taurus to Enhance Digital Asset Solutions as Corporate Customers Show Mixed PerformanceIn a strategic move to strengthen its digital assets capabilities, State Street Corporation (NYSE: STT) has announced a groundbreaking agreement with Taurus SA, a global leader in digital asset infrastr...
|
More News
|
 Business Update
In a significant step forward in the treatment of diabetic macular edema (DME), Merck (NYSE: MRK), known as MSD outside the United States and Canada, and its wholly-owned subsidiary EyeBio have announced the initiation of the Phase 2b/3 BRUNELLO clinical trial for Restoret (MK-3000, formerly EYE103). This investigat...
|
 Business Update
By In a noteworthy move set to propel the burgeoning field of gene therapy forward, Liberate Bio has announced its integration of Quantum-Si s next-generation protein sequencing platform into its research and development processes. This partnership is poised to bring about advancements in the precision and efficien...
|
 Clinical Study
The release of positive topline data by Biogen Inc. (Nasdaq: BIIB) from the Phase 2/3 DEVOTE study represents a crucial advancement in the treatment landscape for spinal muscular atrophy (SMA). Announced on September 4, 2024, these findings highlight the efficacy and safety of a higher dose regimen of nusinersen in ...
|
 Management Changes
Nayax Ltd. a leading global provider of cashless payment solutions, recently made a significant change in its executive leadership by appointing Keren Sharir to the newly created role of President, in addition to her current position as Chief Marketing Officer. The decision comes at a crucial time for the...
|
 Licensing Agreement
iRhythm Technologies Enters License Agreement with BioIntelliSense for Advanced Ambulatory Cardiac Monitoring Solutions In a strategic move that stands to enhance the capabilities of ambulatory cardiac monitoring (ACM), iRhythm Technologies has entered into a licensing agreement with BioIntelliSense. This agreement ...
|
 Clinical Study
: This article discusses Psyence Biomed’s recent licensing agreement with PsyLabs to supply nature-derived psilocybin for clinical evaluation in the treatment of Alcohol Use Disorder (AUD) and other Substance Use Disorders (SUDs). It also examines the company s underlying market performance over the past year co...
|
 Clinical Study
On September 4, 2024, Invivyd, Inc. announced the dosing of its first participants in a Phase 1 clinical trial for VYD2311, a next-generation monoclonal antibody (mAb) candidate targeting COVID-19. This development is significant as VYD2311 has demonstrated high in vitro neutralization potency against various post-O...
|
 Announcement
In the rapidly evolving world of digital media, optimization technologies are becoming imperative for companies seeking to deliver high-quality video content efficiently. Beamr Imaging Ltd. a prominent player in this domain, is poised to spotlight its innovative solutions at the upcoming H.C. Wainwright 26th Annual ...
|
 Announcement
Shoham, Israel, Sept. 4, 2024 - At this year s Commercial UAV Expo in Las Vegas, a flagship event running from September 3-5 that showcases the forefront of uncrewed autonomous systems, Mobilicom Limited (Nasdaq: MOB, MOBBW) has launched its much-anticipated next-generation 8-inch Controller Pro Ground Control Stat...
|
 Clinical Study
Dianthus Therapeutics Inc. (NASDAQ: DNTH), a promising player in the biopharmaceutical sector, is gearing up to participate in three significant healthcare investor conferences this September. As the company continues to push the boundaries of research and development in therapeutics, these engagements offer a cruci...
|
 Clinical Study
Eledon Pharmaceuticals, a pioneering biotechnology company focused on advancing therapies for patients requiring organ transplants, has recently announced the successful completion of enrollment for its Phase 2 BESTOW clinical trial. This trial evaluates the efficacy of Tegoprubart in preventing organ rejection amon...
|
|
Clinical Study
In a significant leap forward in the quest for effective migraine treatments, Axsome Therapeutics has announced the FDA s acceptance of their New Drug Application (NDA) resubmission for AXS-07, a promising candidate for the acute treatment of migraine. With the decision paving the way for review, all eyes are on the...
|
 Financing Agreement
Date: September 4, 2024
Kimco Realty, a prominent real estate investment trust (REIT) specializing in high-quality, open-air, grocery-anchored shopping centers and mixed-use properties across the United States, has announced today that it has successfully amended and upsized its unsecured term loan facility. The loan facility has now been increased from $500 million to an impressive $550 million, providing Kimco with additional capital to pursue its growth objectives.
This strategic move by Kimco Realty comes amidst a period where the Real Estate Investment Trusts (REITs) industry is witnessing several companies striving to boost their income per employee. Although Kimco Realtyns income per employee grew during the first quarter of 2024, it remained below the company average. However, it is worth noting that 25 other REITs have surpassed Kimco Realty in achieving higher income per employee, indicating a competitive landscape within the industry.
|
 Contract
Transocean Ltd. has announced a significant new contract, enhancing its position in the offshore drilling sector. The company, headquartered in Steinhausen, Switzerland, revealed on September 4, 2024, that Reliance Industries Limited has awarded a binding Letter of Award for the ultra-deepwater drillship, Dhirubhai...
|
 Contract
In a notable stride towards optimizing its portfolio, Global Net Lease (GNL) has announced the successful sale of two significant properties: the Plant Shopping Center and the Foster Wheeler Office. These transactions are part of GNL s ongoing strategic disposition initiative, which has garnered an impressive total ...
|
 Business Update
The Transformative Role of Continuous Glucose Monitoring in Diabetes Management In the rapidly evolving landscape of diabetes management, DexCom, Inc. emerges as a pivotal player, showcasing its real-time continuous glucose monitoring (CGM) technology at the renowned European Association for the Study of Diabetes (E...
|
|
|
|
|
